Tempest Therapeutics, Inc. (TPST): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 17:27 ET
- Event date
- 2026-11-13
- Accession no.
- 0001213900-26-119916
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Tempest reports third quarter 2026 results and substantial doubt about going concern
Tempest reported a $3.6 million net loss for the quarter ended September 30, 2026 and $0.9 million in cash and cash equivalents at quarter-end. It said substantial doubt exists about its ability to continue as a going concern. The company also disclosed financing activity and an exclusive license to Senlang’s CD7-targeted lentiviral platform and associated in vivo CAR-T candidates outside China.
- Quarterly net loss was $3.6 million, or $0.21 per share, compared to $3.5 million and $0.79 per share a year earlier.
- Cash and cash equivalents were $0.9 million at quarter-end, compared to $7.7 million on December 31, 2025.
- September 2026 private placement generated gross proceeds of approximately $2.5 million.
- Tempest licensed Senlang’s CD7-targeted lentiviral platform and associated in vivo CAR-T candidates worldwide, excluding China.
earningsfinancingmaterial agreement
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0312157-8k_tempest.htm |
| EX-99.1 | PRESS RELEASE DATED NOVEMBER 13, 2026 | ea031215701ex99-1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.